Opioids Archives

Healthcare Industry News Weekly Wrap-Up: May 23, 2024

// Biotech and Pharma Therapeutics Regeneron faces new biosimilar threats; an AI biotech lays off staff May 22, 2024 / Regeneron Biosimilars / Boehringer Ingelheim / OSE Deal / GSK Regeneron faces new competition from FDA-approved biosimilars for Eylea. Boehringer...

May 23, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: May 9, 2024

// Biotech and Pharma Therapeutics AstraZeneca withdraws COVID-19 vaccine, citing declining demand May 8, 2024 / AstraZeneca / Covid-19 / Vaccine Like other companies that successfully developed a coronavirus shot during the pandemic, AstraZeneca is grappling with a seismic shift...

May 9, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: May 2, 2024

// Biotech and Pharma Therapeutics FTC targets ‘junk patents’ on Ozempic, other top drugs May 1, 2024 / Ozempic / FDA / Drug Pricing / FDA The FTC is targeting over 300 patents associated with top-selling drugs like Ozempic, aiming...

May 2, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: April 25, 2024

// Biotech and Pharma Therapeutics Bristol Myers taps startup to boost cell therapy production April 22, 2024 / Cell Therapy / CAR-T Therapies / Bristol Myers Squibb / Partnership Bristol Myers Squibb has partnered with Cellares, a California-based startup, to...

April 25, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: April 18, 2024

// Biotech and Pharma Therapeutics Lilly obesity drug shows benefit in sleep disorder study, pointing to new use April 17, 2024 / Eli Lilly / Obesity / Sleep Disorder / GLP-1 / Clinical Trials Fresh clinical trial results for Eli...

April 18, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: February 22, 2024

// Biotech and Pharma Therapeutics Phage therapy: Researchers sharpen another arrow in the quiver against antibiotic resistance February 20, 2024 / Antibiotic Resistance / New Drug “It just got so frustrating over the years because we couldn’t find the source,...

February 22, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: February 9, 2024

// Biotech and Pharma Therapeutics BridgeBio sells partial rights to dwarfism drug for $100M February 7, 2024 / BridgeBio / Kyowa Kirin / BioMarin Achondroplasia is the most common form of dwarfism and is caused by alterations to a gene...

February 9, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: January 4, 2024

// Biotech and Pharma Therapeutics AI is ‘not a panacea’ for all drug discovery challenges, but partnerships can be for Generate January 4, 2024 / Generate Biomedicines / AI / Drug Discovery / Machine Learning The geniuses of biotech—the Mozarts...

January 5, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: December 29, 2023

// Biotech and Pharma Therapeutics How Merck extended its monopoly on a blockbuster diabetes drug December 23, 2023 / Merk / Diabetes / Regulators Merck’s monopoly on a blockbuster diabetes drug that has generated about $50 billion in global sales...

December 29, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: December 22, 2023

// Biotech and Pharma Therapeutics Tome Biosciences debuts with $213M and a new way to edit the genome December 12, 2023 / Tome Biosciences / Gene Editing / DNA / Startup Biotechnology startup Tome Biosciences emerged from stealth on Tuesday...

December 22, 2023

1 2 3 4

Tag: Opioids